摘要
肝素诱导的血小板减少症(HIT)是肝素治疗的常见并发症。HIT的主要并发症并非出血性疾病,而是血栓形成。50%的HIT患者有发生血栓形成的风险。虽然近数年加强了HIT诊断和治疗的研究,但仍有许多问题尚未解决。此文对目前HIT的最佳诊断策略进行讨论。
出处
《疑难病杂志》
CAS
2013年第2期161-163,共3页
Chinese Journal of Difficult and Complicated Cases
参考文献20
-
1Linkins LA,Dans AL,Moores LK. Trentment and prevention of heparin-induced thrombocytopenia:antithrombotic therapy and prevention of thrombosis,9th ed:American College of Chest Physicians evidence-based clinical practice guidelines[J].Chest,2012,(2 Suppl):e495S-e530S.
-
2Warkentin TE,Cook RJ,Marder VJ. Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis:the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization[J].Journal of Thrombosis and Haemostasis,2010,(03):504-512.
-
3Arepally GM,Qrtel TL. Heparin-induced thrombocytopenia[J].Annual Review of Medicine,2010.77-90.
-
4Warkentin TE,Sheppard JA,Sigouin CS. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia[J].Blood,2006,(09):2937-2941.
-
5Greinacher A,Farner B,Kroll H. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis.A retrospective analysis of 408 patients[J].Thrombosis and Haemostasis,2005,(01):132-135.
-
6Warkentin TE,Kelton JG. Temporal aspects of heparininduced thrombocytopenia[J].New England Journal of Medicine,2001,(17):1286-1292.
-
7Lubenow N,Kempf R,Eichner A. Heparin-induced thrombocytopenia:temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin[J].Chest,2002,(01):37-42.
-
8Warkentin TE,Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis[J].Annals of Internal Medicine,2001,(07):502-506.
-
9Warkentin TE,Sheppard JA,Horsewood P. Impact of the patient population on the risk for heparin-induced thrombocytopenia[J].Blood,2000,(05):1703-1708.
-
10Lillo-Le Louёt A,Boutouyrie P,Alhenc-Gelas M. Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass[J].Journal of Thrombosis and Haemostasis,2004,(11):1882-1888.
同被引文献53
-
1季闽春,钱庆庆,杨耀芳.肝素诱导的血小板减少症的病因、诊断和治疗研究进展[J].中国临床药理学杂志,2007,23(6):461-465. 被引量:21
-
2刘新,李爱.输血后紫癜[J].山东医药,2005,45(16):76-77. 被引量:2
-
3赵彬,梅丹,李拥军,管珩.肝素诱导的血小板减少症[J].中国药师,2007,10(8):822-824. 被引量:12
-
4Oler A,Whooley MA,Oler J,et al.Adding heparin to aspirin re-duces the incidence of myocardial infarction and death in patientswith unstable angina.A meta-analysis[J].JAMA,1996,276(10):811-815.
-
5Jneid H,Anderson JL,Wright RS,et al.2012 ACCF/AHA focusedupdate of the guideline for the management of patients with unstableangina/not-ST-elevation myocardial infarction(updating the2007 guideline and replacing the 2011 focused update):a report ofthe Americane College of Cardiology Foundation/American HeartAssociation Task force on Practice Guideline[J].J Am Coll Cardi-ol,2012,60(7):645-681.
-
6Sakhuja R,Yeh RW,Bhatt DL.Anticoagulant agents in acute coro-nary syndrome[J].Curr Probl Cardiol,2011,36(4):127-168.
-
7Granger CB,Hirsch J,Califf RM,et al.Activated partial thrombo-plastin time and outcome after thrombolytic therapy for acute myo-cardial infarction:results from the GUSTO-I trial[J].Circula-tion,1996,93(5):870-878.
-
8Levine GN,Bates ER,Blankenship JC,et al.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention:a report ofthe American College of Cardiology Foundation/American Heart As-sociation Task force on Practice Guideline and the Society for Cardi-ovascular Angiography and Interventions[J].J Am Coll Cardiol,2011,58(24):e44-el22.
-
9Makris M,Van Veen JJ,Tait CR,et al.Guideline on the manage-ment of bleeding in patients on antithrombotic agents[J].BritishJournal of Haematology,2012,160(1):35-46.
-
10Linkins LA,Dans AL,Moores LK,et al.Trentment and preventionof heparin-induced thrombocytopenia:antithrombotic therapy andprevention of thrombosis,9th ed:American College of Chest Physi-cians evidence-based clinical practice guidelines[J].Chest,2012,141(2 Suppl):e495S-e530S.
引证文献5
-
1张凯,赵梦华,石建平.肝素治疗急性冠状动脉综合征的研究现状[J].现代中西医结合杂志,2014,23(11):1247-1249. 被引量:1
-
2刘俊,韦俊.依诺肝素钠诱导血小板减少症[J].药物不良反应杂志,2014,16(3):181-182. 被引量:5
-
3余茂生,盛国太,谢国波,李华泰,葛郁芝.肝素、低分子肝素诱导的重症血小板减少2例救治分析[J].医学与哲学(B),2014,35(10):63-64. 被引量:1
-
4董晖,郭永秋,史欢.肝素诱导血小板减少症诊断进展[J].齐齐哈尔医学院学报,2014,35(23):3530-3533.
-
5李光海,高文婷,宋志英,张望德.急性DVT抗凝治疗致Ⅱ型肝素诱导血小板减少症一例[J].临床误诊误治,2017,30(1):73-76. 被引量:9
二级引证文献16
-
1章毅.尿激酶肝素混合封管在带涤纶套双腔透析导管中的应用效果[J].透析与人工器官,2020(2):13-15. 被引量:3
-
2胡霞,杨海波,赵荫涛,李凌,张晋东.再次应用肝素和盐酸替罗非班导致极重度血小板减少伴亚急性支架内血栓形成1例报道[J].医学与哲学(B),2016,37(2):71-73. 被引量:1
-
3孟庆义.咯血病因诊断的五步思维[J].临床误诊误治,2017,30(7):1-5. 被引量:2
-
4刘育慧,任志学,张淑兰,郑立平,王世荣,王刚,耿清峰,曹淑玲,尹淑利,安丽伟.比伐卢定用于高危急性冠脉综合征病人PCI术中的疗效及安全性研究[J].中西医结合心脑血管病杂志,2017,15(13):4620-4623. 被引量:9
-
5杜春辉,李佳,赵庆国,陈杰.1例疑似依诺肝素钠致血小板增多症的病例分析[J].中南药学,2017,15(5):697-699. 被引量:6
-
6李歌平,费燕.1例低分子肝素钠引起血小板减少症患者的药学服务[J].中国继续医学教育,2017,9(35):93-95.
-
7王彦江,谢席胜,冯胜刚.依诺肝素在血液透析抗凝治疗中的应用优势[J].西部医学,2018,30(2):231-233. 被引量:13
-
8贾蕊.脑外伤合并多发伤患者深静脉血栓形成相关因素及护理预防对策[J].河南医学高等专科学校学报,2018,30(3):303-305. 被引量:2
-
9吴海波,李建成,侯立栋,迟满丽,吴艳慧,刘洋.依诺肝素钠在恶性肿瘤化疗中对深静脉血栓的预防价值及安全性[J].中国实用医药,2018,13(20):111-112. 被引量:1
-
10陈治水,薛成军,崔丽娟.血细胞分析仪测定抗凝剂对血小板的影响[J].河南医学研究,2018,27(16):2958-2959. 被引量:2
-
1李贵双.肝素诱导的血小板减少症及血栓形成综合征[J].医学综述,1998,4(5):239-241.
-
2杨仁池.肝素诱导的血小板减少症[J].国外医学(输血及血液学分册),1998,21(5):274-277. 被引量:3
-
3刘泽霖.肝素导致血小板减少[J].血栓与止血学,2004,10(4):187-190. 被引量:3
-
4Crem.,P,郭志凌.脂质代谢紊乱的诊断策略与治疗[J].德国医学,1993,10(1):41-43.
-
5李英.肺栓塞诊断策略的探讨[J].临床中老年保健,2002,5(2):152-154. 被引量:1
-
6邓朝胜,林其昌,王辰.老年人肺栓塞的特点和肺血栓栓塞症诊断策略[J].中华老年医学杂志,2008,27(1):12-13. 被引量:14
-
7赵彦,宋林萱,徐晶.类风湿关节炎患者合并发热和肺部病变的诊断和鉴别诊断[J].中国伤残医学,2015,23(19):115-116. 被引量:1
-
8王继贵.心肌梗塞诊断试验的评价[J].中国检验医学与临床,2002,3(3):100-102.
-
9邵超华,王蔚浩,付熠,胡浩荣,李少明.急性心肌梗死患者血脑钠肽前体水平与心功能的关系[J].山东医药,2010,50(13):84-85. 被引量:4
-
10王伟岸,胡品津,焦志勇.肠易激综合征治疗学进展[J].胃肠病学和肝病学杂志,2002,11(4):315-319. 被引量:3